Why the study?
Does open Roux-en-Y gastric bypass surgery improve weight loss and resolve comorbidities in morbidly obese patients?
Does open Roux-en-Y gastric bypass surgery improve weight loss and resolve comorbidities in morbidly obese patients?
Open Roux-en-Y gastric bypass surgery in a real-world public healthcare setting significantly reduced BMI and resolved major cardiometabolic comorbidities in morbidly obese patients at 12 months.
Bariatric surgery linked to high comorbidity resolution except CVD; hypothesis-generating and leaves open need for prospective cardiovascular outcome trials.
BACKGROUND: This study aimed to evaluate the waiting time, safety, and effectiveness of bariatric surgery based on real-world data. METHODS: This is a noninterventional, noncomparative, and retrospective study with 300 morbidly obese patients who had undergone open Roux-en-Y surgery. RESULTS: ). Comorbidity resolution was over 90% for all conditions, except for cardiovascular disease, which showed a 40% resolution. The mean number of drugs taken also decreased at 12 months after surgery. CONCLUSIONS: Bariatric surgery was found to be effective in weight reduction and in the resolution of comorbidities.
No takes yet. Share an insight, caveat, or question.
Rasera et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: